Skip to main content
Erschienen in: Clinical Rheumatology 2/2014

01.02.2014 | Original Article

Occupational exposure in patients with the antisynthetase syndrome

verfasst von: Ane Labirua-Iturburu, Albert Selva-O’Callaghan, Jan-Paul Zock, Ramon Orriols, Xavier Martínez-Gómez, Miquel Vilardell-Tarrés

Erschienen in: Clinical Rheumatology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Interstitial lung disease (ILD) is common in patients with myositis and is related with the presence of antisynthetase autoantibodies (aSA). Together with other manifestations, the resulting condition is known as the antisynthetase syndrome (ASS). Contact with certain environmental and occupational agents is also associated with the development of ILD. The objective of this study was to analyze occupational exposure and associated clinical manifestations in a cohort of patients with ASS. aSA had been identified by line immunoassay and confirmed by immunoprecipitation. Serial pulmonary function tests had been carried out to assess lung function. Thirty-two ASS patients and a control group of 32 myositis patients without aSA underwent a specific questionnaire interview to evaluate their cumulative exposure to biological dust, mineral dust, and gases/fumes up to disease onset. Comparisons were done with the Fisher exact test and Mann–Whitney test. Out from 32 ASS patients (median age, 42.7 yeras; IQR 32.2–52.5), twenty-six patients had anti-Jo-1, three anti-PL-12, and three anti-PL-7. Nine had polymyositis, 15 dermatomyositis, one amyopathic dermatomyositis, and seven pure ILD without myositis. Sixteen ASS patients (50 %) and seven (22 %) myositis patients without aSA had ever been highly exposed to dust, gases, or fumes (p < 0.05). A more than 10 % improvement in forced vital capacity occurred in 61 % of highly exposed patients and 23 % of those with low/no exposure (p = 0.06) over the observation period. In conclusion, a high percentage of patients with ASS had been exposed to dusts, gases, or fumes.
Literatur
1.
2.
Zurück zum Zitat Connors GR, Christopher-Stine L, Oddis CV, Danoff SK (2010) Interstitial lung disease associated with the idiopathic inflammatory myopathies. What progress has been made in the past 35 years? Chest 138:1464–1474PubMedCrossRef Connors GR, Christopher-Stine L, Oddis CV, Danoff SK (2010) Interstitial lung disease associated with the idiopathic inflammatory myopathies. What progress has been made in the past 35 years? Chest 138:1464–1474PubMedCrossRef
3.
Zurück zum Zitat Labirua A, Lundberg IE (2010) Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls. Curr Opin Rheumatol 22:633–638PubMedCrossRef Labirua A, Lundberg IE (2010) Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls. Curr Opin Rheumatol 22:633–638PubMedCrossRef
4.
Zurück zum Zitat Selva-O’Callaghan A, Labrador-Horrillo M, Solans-Laque R, Simeon-Aznar CP, Martínez-Gómez X, Vilardell-Tarrés M (2006) Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Arthritis Rheum 55:791–798PubMedCrossRef Selva-O’Callaghan A, Labrador-Horrillo M, Solans-Laque R, Simeon-Aznar CP, Martínez-Gómez X, Vilardell-Tarrés M (2006) Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Arthritis Rheum 55:791–798PubMedCrossRef
5.
6.
Zurück zum Zitat Levine SM, Raben N, Xie D, Askin FB, Tuder R, Mullins M et al (2007) Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis. Arthritis Rheum 56:2729–2739PubMedCrossRef Levine SM, Raben N, Xie D, Askin FB, Tuder R, Mullins M et al (2007) Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis. Arthritis Rheum 56:2729–2739PubMedCrossRef
7.
Zurück zum Zitat Tillie-Leblond I, Wislez M, Valeyre D, Crestani B, Rabbat A, Israel-Biet D et al (2008) Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset. Thorax 63:53–59PubMedCrossRef Tillie-Leblond I, Wislez M, Valeyre D, Crestani B, Rabbat A, Israel-Biet D et al (2008) Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset. Thorax 63:53–59PubMedCrossRef
8.
Zurück zum Zitat Labirua-Iturburu A, Selva-O’Callaghan A et al. (2012) Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature. Medicine (Baltimore) (in press) Labirua-Iturburu A, Selva-O’Callaghan A et al. (2012) Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature. Medicine (Baltimore) (in press)
9.
Zurück zum Zitat Serratrice J, Granel B, Pache X et al (2001) A case of polymyositis with anti-histidyl-t-RNA synthetase (Jo-1) antibody syndrome following extensive vinyl chloride exposure. Clin Rheumatol 20:379–382PubMedCrossRef Serratrice J, Granel B, Pache X et al (2001) A case of polymyositis with anti-histidyl-t-RNA synthetase (Jo-1) antibody syndrome following extensive vinyl chloride exposure. Clin Rheumatol 20:379–382PubMedCrossRef
10.
Zurück zum Zitat Scott J, Johnston I, Britton J (1990) What causes fibrosing alveolitis? A case–control study of environmental exposure to dust. BMJ 301:1015–1017PubMedCrossRef Scott J, Johnston I, Britton J (1990) What causes fibrosing alveolitis? A case–control study of environmental exposure to dust. BMJ 301:1015–1017PubMedCrossRef
11.
Zurück zum Zitat Iwai K, Mori T, Yamada N, Yamaguchi M, Hosoda Y (1994) Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. Am J Respir Crit Care Med 150:670–675PubMedCrossRef Iwai K, Mori T, Yamada N, Yamaguchi M, Hosoda Y (1994) Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. Am J Respir Crit Care Med 150:670–675PubMedCrossRef
12.
Zurück zum Zitat Moya C, Anot JM, Newman-Taylor AJ (1994) Outbreak of organising pneumonia in textile printing sprayers. Lancet 344:498–452PubMedCrossRef Moya C, Anot JM, Newman-Taylor AJ (1994) Outbreak of organising pneumonia in textile printing sprayers. Lancet 344:498–452PubMedCrossRef
13.
Zurück zum Zitat Hubbard L, Lewis S, Richards K, Johnston I, Britton J (1996) Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet 347:284–289PubMedCrossRef Hubbard L, Lewis S, Richards K, Johnston I, Britton J (1996) Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet 347:284–289PubMedCrossRef
14.
Zurück zum Zitat Baumgartner KB, Samet JM et.al. (1997) Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case control study. Am J Epidemiol 145: s61 Baumgartner KB, Samet JM et.al. (1997) Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case control study. Am J Epidemiol 145: s61
15.
Zurück zum Zitat Hubbard R, Cooper M, Antoniak M et al (2000) Risk of cryptogenic fibrosing alveolitis in metal workers. Lancet 355:466–467PubMed Hubbard R, Cooper M, Antoniak M et al (2000) Risk of cryptogenic fibrosing alveolitis in metal workers. Lancet 355:466–467PubMed
16.
Zurück zum Zitat Hubbard R (2001) Occupational dust exposure and the aetiology of cryptogenic fibrosing alveolitis. Eur Respir J 18(Suppl 32):119s–121s Hubbard R (2001) Occupational dust exposure and the aetiology of cryptogenic fibrosing alveolitis. Eur Respir J 18(Suppl 32):119s–121s
17.
Zurück zum Zitat Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292(344–7):403–407PubMedCrossRef Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292(344–7):403–407PubMedCrossRef
18.
Zurück zum Zitat Sontheimer RD (1999) Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis. Curr Opin Rheumatol 11:475–482PubMedCrossRef Sontheimer RD (1999) Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis. Curr Opin Rheumatol 11:475–482PubMedCrossRef
19.
Zurück zum Zitat Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC (1993) Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 16:5–40 Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC (1993) Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 16:5–40
20.
Zurück zum Zitat Roca J, Sanchis J, Agusti-Vidal A, Segarra F, Navajas D, Rodriguez-Roisin R et al (1986) Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir 22:217–224PubMed Roca J, Sanchis J, Agusti-Vidal A, Segarra F, Navajas D, Rodriguez-Roisin R et al (1986) Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir 22:217–224PubMed
21.
Zurück zum Zitat Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK et al (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824PubMedCrossRef Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK et al (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824PubMedCrossRef
22.
Zurück zum Zitat Ghirardello A, Rampudda M, Ekholm L, Bassi N, Tarricone E, Zampieri S et al (2010) Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. Rheumatology (Oxford) 49:2370–2374CrossRef Ghirardello A, Rampudda M, Ekholm L, Bassi N, Tarricone E, Zampieri S et al (2010) Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. Rheumatology (Oxford) 49:2370–2374CrossRef
23.
Zurück zum Zitat International Labour Office (1991) International Standard Classification of Occupations: ISCO 88. ILO: Geneva International Labour Office (1991) International Standard Classification of Occupations: ISCO 88. ILO: Geneva
24.
Zurück zum Zitat Matheson MC, Benke G, Raven J, Sim MR, Kromhout H, Vermeulen R, Johns DP, Walters EH, Abramson MJ (2005) Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease. Thorax 60:645–651PubMedCrossRef Matheson MC, Benke G, Raven J, Sim MR, Kromhout H, Vermeulen R, Johns DP, Walters EH, Abramson MJ (2005) Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease. Thorax 60:645–651PubMedCrossRef
25.
Zurück zum Zitat Sunyer J, Zock JP, Kromhout H, Garcia-Esteban R, Radon K, Jarvis D, Toren K, Künzli N, Norbäck D, d’Errico A, Urrutia I, Payo F, Olivieri M, Villani S, van Sprundel M, Antó JM, Kogevinas M (2005) Lung function decline, chronic bronchitis and occupational exposures in young adults. Am J Respir Crit Care Med 172:1139–1145PubMedCrossRef Sunyer J, Zock JP, Kromhout H, Garcia-Esteban R, Radon K, Jarvis D, Toren K, Künzli N, Norbäck D, d’Errico A, Urrutia I, Payo F, Olivieri M, Villani S, van Sprundel M, Antó JM, Kogevinas M (2005) Lung function decline, chronic bronchitis and occupational exposures in young adults. Am J Respir Crit Care Med 172:1139–1145PubMedCrossRef
26.
Zurück zum Zitat Miller FW, Hess EV, Clauw DJ et al (2000) Approaches for identifying and defining environmentally associated rheumatic disorders. Arthritis Rheum 43:343–349 Miller FW, Hess EV, Clauw DJ et al (2000) Approaches for identifying and defining environmentally associated rheumatic disorders. Arthritis Rheum 43:343–349
27.
28.
Zurück zum Zitat Selva-O’Callaghan A, Tura JM, Grau-Junyent JM, Labrador-Horrillo M, Solans-Laque R, Vilardell-Tarrés M (2004) Silicone gel filled breast implants and dermatomyositis. Clin Exp Rheumatol 22:376PubMed Selva-O’Callaghan A, Tura JM, Grau-Junyent JM, Labrador-Horrillo M, Solans-Laque R, Vilardell-Tarrés M (2004) Silicone gel filled breast implants and dermatomyositis. Clin Exp Rheumatol 22:376PubMed
29.
Zurück zum Zitat Slimani S, Ben Ammar A, Ladjouze-Rezig A (2010) Connective tissue diseases after heavy exposure to silica: a report of nine cases in stonemasons. Clin Rheumatol 29:531–533PubMedCrossRef Slimani S, Ben Ammar A, Ladjouze-Rezig A (2010) Connective tissue diseases after heavy exposure to silica: a report of nine cases in stonemasons. Clin Rheumatol 29:531–533PubMedCrossRef
30.
Zurück zum Zitat Sanchez-Roman J, Wichmann I, Salaberri J, Varela JM, Nuñez-Roldan A (1993) Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica. Ann Rheum Dis 52:534–538PubMedCrossRef Sanchez-Roman J, Wichmann I, Salaberri J, Varela JM, Nuñez-Roldan A (1993) Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica. Ann Rheum Dis 52:534–538PubMedCrossRef
31.
Zurück zum Zitat Chinoy H, Adimulam S, Marriage F, New P, Vincze M, Zilahi E, Kapitány A, Gyetvai A, Ekholm L, Novota P, Remakova M, Charles P, McHugh NJ, Padyukov L, Alfredsson L, Vencovsky J, Lundberg IE, Danko K, Ollier WE, Cooper RG (2012) Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study. Ann Rheum Dis 71:961–965PubMedCentralPubMedCrossRef Chinoy H, Adimulam S, Marriage F, New P, Vincze M, Zilahi E, Kapitány A, Gyetvai A, Ekholm L, Novota P, Remakova M, Charles P, McHugh NJ, Padyukov L, Alfredsson L, Vencovsky J, Lundberg IE, Danko K, Ollier WE, Cooper RG (2012) Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study. Ann Rheum Dis 71:961–965PubMedCentralPubMedCrossRef
32.
Zurück zum Zitat Zock JP, Cavallé N, Kromhout H, Kennedy SM, Sunyer J, Jaén A, Muniozguren N, Payo F, Almar E, Sánchez JL, Antó JM, Kogevinas M (2004) Evaluation of specific occupational asthma risks in a community-based study with special reference to single and multiple exposures. J Expo Anal Environ Epidemiol 14:397–403PubMedCrossRef Zock JP, Cavallé N, Kromhout H, Kennedy SM, Sunyer J, Jaén A, Muniozguren N, Payo F, Almar E, Sánchez JL, Antó JM, Kogevinas M (2004) Evaluation of specific occupational asthma risks in a community-based study with special reference to single and multiple exposures. J Expo Anal Environ Epidemiol 14:397–403PubMedCrossRef
33.
Zurück zum Zitat Sunyer J, Kogevinas M, Kromhout H, Antó JM, Roca J, Tobias A, Vermeulen R, Payo F, Maldonado JA, Martinez-Moratalla J, Muniozguren N (1998) Pulmonary ventilatory defects and occupational exposures in a population-based study in Spain. Am J Respir Crit Care Med 157:512–517PubMedCrossRef Sunyer J, Kogevinas M, Kromhout H, Antó JM, Roca J, Tobias A, Vermeulen R, Payo F, Maldonado JA, Martinez-Moratalla J, Muniozguren N (1998) Pulmonary ventilatory defects and occupational exposures in a population-based study in Spain. Am J Respir Crit Care Med 157:512–517PubMedCrossRef
Metadaten
Titel
Occupational exposure in patients with the antisynthetase syndrome
verfasst von
Ane Labirua-Iturburu
Albert Selva-O’Callaghan
Jan-Paul Zock
Ramon Orriols
Xavier Martínez-Gómez
Miquel Vilardell-Tarrés
Publikationsdatum
01.02.2014
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 2/2014
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2467-0

Weitere Artikel der Ausgabe 2/2014

Clinical Rheumatology 2/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.